Bergmann Anthony (CIK 1593087) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-29). Recent activity: Buy CAPR (24,100 shares), Sell CAPR (24,100 shares), Buy CAPR (500 shares), Sell CAPR (500 shares), Buy CAPR (400 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-29 | CAPRICOR THERAPEUTICS, INC. (CAPR) | CHIEF FINANCIAL OFFICER | Buy | 24,100 | $76,638 |
| 2026-06-29 | CAPRICOR THERAPEUTICS, INC. (CAPR) | CHIEF FINANCIAL OFFICER | Sell | 24,100 | $732,158 |
| 2026-06-24 | CAPRICOR THERAPEUTICS, INC. (CAPR) | CHIEF FINANCIAL OFFICER | Buy | 500 | $1,590 |
| 2026-06-24 | CAPRICOR THERAPEUTICS, INC. (CAPR) | CHIEF FINANCIAL OFFICER | Sell | 500 | $15,000 |
| 2026-06-24 | CAPRICOR THERAPEUTICS, INC. (CAPR) | CHIEF FINANCIAL OFFICER | Buy | 400 | $1,272 |
| 2026-06-24 | CAPRICOR THERAPEUTICS, INC. (CAPR) | CHIEF FINANCIAL OFFICER | Sell | 400 | $12,000 |
| 2026-05-19 | CAPRICOR THERAPEUTICS, INC. (CAPR) | CHIEF FINANCIAL OFFICER | Buy | 3,000 | $4,170 |
| 2026-05-04 | CAPRICOR THERAPEUTICS, INC. (CAPR) | CHIEF FINANCIAL OFFICER | Buy | 25,000 | $79,500 |
| 2026-05-04 | CAPRICOR THERAPEUTICS, INC. (CAPR) | CHIEF FINANCIAL OFFICER | Sell | 25,000 | $792,500 |
| 2026-04-01 | CAPRICOR THERAPEUTICS, INC. (CAPR) | CHIEF FINANCIAL OFFICER | Buy | 25,000 | $79,500 |
| 2026-04-01 | CAPRICOR THERAPEUTICS, INC. (CAPR) | CHIEF FINANCIAL OFFICER | Sell | 25,000 | $753,250 |
来源：SEC Form 4 申报文件 · 截至 2026-06-29